You specified executive function and you scored a direct hit.
Ira Shoulson said from the Alzheimer's results he thought it could help with executive function decline in HD and he was correct.
This bodes very well for the coming AD results and extension trial. It has helped in brain atrophy, so there is a biomarker to back up the cognition result, and of course it passed the primary endpoint of safety with flying colors.
Bring on the phase3 and the IMAGINE results.
Holding through AD results.
congratulations prana
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $18.65K | 5.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 57052005 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 125915200 | 27 |
View Market Depth
| Last trade - 14.28pm 29/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |